anonymous
Guest
anonymous
Guest
Really feels like we are becoming the sales team in medical. Medical leadership focusing on reach and frequency and proactive engagement. Could be problems for Pfizer Oncology in the future if this continues. I don't think it's ethical for medical teams to be proactive likes sales organizations. Really seems that's what's going on. Pfizer Leadership needs to have a serious discussion with Oncology Medical Leadership to protect Pfizer. We are not salespeople and should only be engaging in a reactive way. I have no desire to help with business, I only want to educate. Am I wrong?